Bristol Myers Squibb Executive Compensation Revealed
Ticker: CELG-RI · Form: DEF 14A · Filed: Mar 26, 2025 · CIK: 14272
| Field | Detail |
|---|---|
| Company | Bristol Myers Squibb Co (CELG-RI) |
| Form Type | DEF 14A |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, annual-filing
Related Tickers: BMY
TL;DR
BMS exec pay details out for 2024, check out Caforio & Boerner's comp.
AI Summary
Bristol Myers Squibb Co. filed its DEF 14A on March 26, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes compensation details for key personnel such as Dr. Giovanni Caforio and Dr. Chris Boerner, with compensation data spanning from 2020 to 2023. Specific tables outline changes in pension values and equity awards for these executives.
Why It Matters
This filing provides transparency into how Bristol Myers Squibb compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing disclosing executive compensation and does not indicate any immediate financial or operational risks.
Key Numbers
- 2024 — Fiscal Year End (The period for which executive compensation is reported.)
- 2023 — Compensation Data Year (Specific compensation details are provided for this year.)
- 2020-2023 — Historical Compensation Data (The filing includes compensation information spanning these years.)
Key Players & Entities
- Bristol Myers Squibb Co. (company) — Filer of the DEF 14A
- Dr. Giovanni Caforio (person) — Executive mentioned in compensation tables
- Dr. Chris Boerner (person) — Executive mentioned in compensation tables
- 2024-12-31 (date) — Fiscal year end for compensation reporting
- 20250326 (date) — Filing date of the DEF 14A
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to disclose information regarding the solicitation of proxies for the company's annual meeting of stockholders, including details on executive compensation.
Who are the key executives whose compensation is detailed in this filing?
Key executives mentioned include Dr. Giovanni Caforio and Dr. Chris Boerner, with compensation data provided for them.
For which fiscal year is the executive compensation primarily reported?
The executive compensation is primarily reported for the fiscal year ending December 31, 2024, with historical data also presented.
What specific types of compensation are detailed for the executives?
The filing details include information on changes in pension values and equity awards for the executives.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on March 26, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 26, 2025 by Dr. Giovanni Caforio regarding BRISTOL MYERS SQUIBB CO (CELG-RI).